Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011052934> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2011052934 endingPage "132" @default.
- W2011052934 startingPage "129" @default.
- W2011052934 abstract "Heparin is often used in progressing ischemic stroke. However, a substantial part of the patients continue to progress while on treatment. The purpose of this study was to evaluate if antithrombin (AT) III activity before treatment could predict patients at risk for continued progression or if heparin-induced reduction in AT-III activity during treatment is related to continued progression. The study included 42 acute stroke patients with heaprin treatment for progression of isch emic stroke. The patients were continuously supervised for progression. Intravenous heparin therapy was started as soon as possible after the progression was noticed. Antithrombin-III activity was assessed before initiation of treatment and daily during the treatment period. Nine (21 %) of the 42 patients continued to progress while on treatment. There was no statis tically significant difference in AT III activity before treatment between patients who continued to progress and those where the progression ceased when treatment was initiated. Nor were there any differences in the mean AT III activity levels during treatment for patients with more or less favorable clinical course. The individual changes (Δ AT III) were similar in both patient groups as was the proportion of patients with their low est AT III activity in the thrombogenic range (continued: 22% vs. ceased: 27%). No clinically relevant influence of AT III activity on heparin efficacy in progressing ischemic stroke was found. Key Words: Stroke progression—Heparin treatment— Antithrombin activity." @default.
- W2011052934 created "2016-06-24" @default.
- W2011052934 creator A5030912466 @default.
- W2011052934 creator A5046191899 @default.
- W2011052934 creator A5050661455 @default.
- W2011052934 date "1998-04-01" @default.
- W2011052934 modified "2023-10-03" @default.
- W2011052934 title "Antithrombin-III Activity and the Efficacy of Heparin in Progressing Ischemic Stroke" @default.
- W2011052934 cites W1988932753 @default.
- W2011052934 cites W1994460021 @default.
- W2011052934 cites W2015730822 @default.
- W2011052934 cites W2023805569 @default.
- W2011052934 cites W2024489177 @default.
- W2011052934 cites W2029780610 @default.
- W2011052934 cites W2034701398 @default.
- W2011052934 cites W2048058798 @default.
- W2011052934 cites W2055002405 @default.
- W2011052934 cites W2067739550 @default.
- W2011052934 cites W2106899268 @default.
- W2011052934 cites W2117819141 @default.
- W2011052934 cites W2122730741 @default.
- W2011052934 cites W2129991925 @default.
- W2011052934 cites W2132710058 @default.
- W2011052934 cites W2141224328 @default.
- W2011052934 cites W2142265119 @default.
- W2011052934 cites W2143246930 @default.
- W2011052934 cites W2155501335 @default.
- W2011052934 cites W2161734786 @default.
- W2011052934 cites W2172079078 @default.
- W2011052934 cites W2560549015 @default.
- W2011052934 cites W33744746 @default.
- W2011052934 doi "https://doi.org/10.1177/107602969800400210" @default.
- W2011052934 hasPublicationYear "1998" @default.
- W2011052934 type Work @default.
- W2011052934 sameAs 2011052934 @default.
- W2011052934 citedByCount "0" @default.
- W2011052934 crossrefType "journal-article" @default.
- W2011052934 hasAuthorship W2011052934A5030912466 @default.
- W2011052934 hasAuthorship W2011052934A5046191899 @default.
- W2011052934 hasAuthorship W2011052934A5050661455 @default.
- W2011052934 hasConcept C126322002 @default.
- W2011052934 hasConcept C127413603 @default.
- W2011052934 hasConcept C2777557582 @default.
- W2011052934 hasConcept C2779026020 @default.
- W2011052934 hasConcept C2780645631 @default.
- W2011052934 hasConcept C3020199598 @default.
- W2011052934 hasConcept C541997718 @default.
- W2011052934 hasConcept C71924100 @default.
- W2011052934 hasConcept C78519656 @default.
- W2011052934 hasConceptScore W2011052934C126322002 @default.
- W2011052934 hasConceptScore W2011052934C127413603 @default.
- W2011052934 hasConceptScore W2011052934C2777557582 @default.
- W2011052934 hasConceptScore W2011052934C2779026020 @default.
- W2011052934 hasConceptScore W2011052934C2780645631 @default.
- W2011052934 hasConceptScore W2011052934C3020199598 @default.
- W2011052934 hasConceptScore W2011052934C541997718 @default.
- W2011052934 hasConceptScore W2011052934C71924100 @default.
- W2011052934 hasConceptScore W2011052934C78519656 @default.
- W2011052934 hasIssue "2" @default.
- W2011052934 hasLocation W20110529341 @default.
- W2011052934 hasOpenAccess W2011052934 @default.
- W2011052934 hasPrimaryLocation W20110529341 @default.
- W2011052934 hasRelatedWork W2011052934 @default.
- W2011052934 hasRelatedWork W2018364642 @default.
- W2011052934 hasRelatedWork W2042576684 @default.
- W2011052934 hasRelatedWork W2067739550 @default.
- W2011052934 hasRelatedWork W2404592538 @default.
- W2011052934 hasRelatedWork W2746744489 @default.
- W2011052934 hasRelatedWork W2886059642 @default.
- W2011052934 hasRelatedWork W2914632596 @default.
- W2011052934 hasRelatedWork W3148882588 @default.
- W2011052934 hasRelatedWork W4317527509 @default.
- W2011052934 hasVolume "4" @default.
- W2011052934 isParatext "false" @default.
- W2011052934 isRetracted "false" @default.
- W2011052934 magId "2011052934" @default.
- W2011052934 workType "article" @default.